美敦力 （Medtronic） 超出了盈利预期，提高了股息，并指引 2026 年更高。 Medtronic beat earnings estimates, raised its dividend, and guided higher for 2026.

全球医疗技术公司Medtronic PLC报告说,第二季度收入强劲,EPS收入为1.26美元,击打估计数为0.3美元,上报收入为8.58亿美元,超过了83.7亿美元的共识。 Medtronic PLC, a global medical technology company, reported strong second-quarter earnings with EPS of $1.26, beating estimates by $0.03, and posted revenue of $8.58 billion, exceeding the $8.37 billion consensus. 股票在第一季度上涨了9.9%,平均移动50天,为91.96美元。 The stock rose 9.9% in the first quarter and has a 50-day moving average of $91.96. 机构投资者拥有该公司的82.06%,而Invesco和Fulton银行增加了股份。 Institutional investors own 82.06% of the company, with Invesco and Fulton Bank increasing their stakes. 麦德特龙公司保持"中等购买"评级,平均目标价格为102.27美元,支付率为78.24%. Medtronic maintains a "Moderate Buy" rating, a $102.27 average price target, and a 78.24% payout ratio. 该公司将季度红利提高到0.71美元,应于10月17日支付,并将2026财政年度指导定为5.60美元至5.66 EPS。 The company raised its quarterly dividend to $0.71, payable October 17, and set FY 2026 guidance at $5.60–$5.66 EPS.